Efficacy and Safety of Direct Oral Anticoagulants Compared With Heparin for Preventing Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis
A high rate of thromboembolism and a high risk of death have been reported regarding hospitalized patients with coronavirus disease 2019 (COVID-19). Recently, we noticed that clinicians in some comparative studies used direct oral anticoagulants (DOACs) to prevent thromboembolism in patients with CO...
Main Authors: | Yong Tian MD, Tao Pan MD, Xudong Wen MD, Guangyu Ao MD, Yihan Ma MD, Xiaoxiao Liu MD, Rui Liu MD, Hongmei Ran MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-05-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296231164355 |
Similar Items
-
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
by: Jie Zeng MSc, et al.
Published: (2019-05-01) -
Factor VIII, Fibrinogen and Heparin Resistance in COVID-19 Patients with Thromboembolism: How Should We Manage the Anticoagulation Therapy?
by: Felicio Savioli MD, MSc, et al.
Published: (2022-03-01) -
Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective
by: Rodrigo Abensur Athanazio MD, PhD, et al.
Published: (2022-03-01) -
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants
by: Yunfeng Zhao MD, PhD, et al.
Published: (2024-04-01) -
The Safety of Direct Oral Anticoagulants Versus Warfarin Among Older Individuals With Acute Venous Thromboembolism and CKD: A Population-Based Cohort Study
by: Ziv Harel, MD, MSc, et al.
Published: (2022-09-01)